Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Oyster Point Pharma, Inc. | d844461dex51.htm |
| EX-1.1 - EX-1.1 - Oyster Point Pharma, Inc. | d844461dex11.htm |
| S-1 - S-1 - Oyster Point Pharma, Inc. | d844461ds1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of Oyster Point Pharma, Inc. of our report dated February 27, 2020 relating to the financial statements, which appears in Oyster Point Pharma, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
| /s/ PricewaterhouseCoopers LLP |
| Florham Park, New Jersey May 12, 2020 |